Home » ROTARIX VACCINE WINS EUROPEAN APPROVAL
ROTARIX VACCINE WINS EUROPEAN APPROVAL
The European Commission has approved GlaxoSmithKline's (GSK) Rotarix vaccine
for the prevention of rotavirus gastroenteritis in children. The product is
the first vaccine against rotavirus available in Europe, GSK has announced.
Rotavirus disease causes the hospitalization of 87,000 babies each year in
Europe, according to the company. The disease is the leading recognized cause
of viral, diarrhea-related illness among infants and young children. Rotarix
has already been licensed in 33 countries, and 1.4 million doses of the vaccine
have been distributed since its first launch in Mexico in 2005.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
07May
-
14May
-
30May